Treosulfan powder for solution for injection or infusion
Vials containing 1 g or 5 g treosulfan.
For the treatment of all types of ovarian cancer, either supplementary to surgery or palliatively. Some uncontrolled studies have suggested activity in a wider range of neoplasms.
Because of a lack of cross-resistance reported between treosulfan and other cytotoxic agents treosulfan may be useful in any neoplasm refractive to conventional therapy.
Treosulfan has been used in combination regimens in conjunction with vincristine, methotrexate, 5-FU and procarbazine.
Pack sizes:
1 g vial N5
5 g vial N5
